Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

A Prada Payday: Is AMC Back in Style?

AMC Entertainment is seeing renewed bullish momentum, driven by a box-office hit and a critical debt restructuring that extends its financial runway.

NVIDIA’s China Connection: Investor Risks With Earnings Ahead

NVIDIA’s China Connection: Investor Risks With Earnings Ahead

NVIDIA faces risks but the rewards outweight them, as upside potential continues to grow under the influence of AI demand.

3 Energy Stocks to Buy and 2 to Avoid as AI Power Demand Explodes

3 Energy Stocks to Buy and 2 to Avoid as AI Power Demand Explodes

Rob Spivey of Altimetry Research breaks down the AI energy boom — naming GE Vernova, Bloom Energy, and Kodiak Gas Services as buys and explaining why NextEra Energy and AECOM may fall behind.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Netflix, Pulte, and Mobileye Are Buying Their Own Dips—Should You?

Netflix leads a list of consumer discretionary stocks adding significant buyback capacity as their shares struggle to move higher.

GameStop's eBay Gamble: Bold Move or Balance Sheet Disaster?

GameStop's unsolicited bid for eBay is likely to fail, leaving the company in need of another strategy and investors in increasing risk.

Big-Tech Earnings: Google and Meta's Results Support Broadcom's Outlook

Google and Meta Platforms are two of Broadcom's top AI chip partners. Their financials and earnings remarks add fuel to Broadcom's fire.

Tyson Foods' Total Returns: Tasty Treats for Income Investors?

Tyson Foods is on track to set fresh highs in Q2, confirming a major market reversal and potential for a 50% upside in this stock.

inkl

Read news from The Economist, FT, and more,
with one subscription

Dividend Boosters: Qualcomm, Southern , PACCAR Add Juice to Yields

Dividend Boosters: Qualcomm, Southern , PACCAR Add Juice to Yields

Qualcomm leads a list of stocks increasing dividends, with its shares seeing a huge spike in April amid artificial intelligence optimism.

5 Mega-Cap Stocks That Beat Q1 2026 Earnings and Are Still Climbing

5 Mega-Cap Stocks That Beat Q1 2026 Earnings and Are Still Climbing

Alphabet, Amazon, Apple, Qualcomm, and Caterpillar all topped Q1 2026 estimates, with standout results in cloud, AI infrastructure, and automotive revenue growth.

Why Lockheed Martin's Earnings Miss Could Be a Blessing in Disguise

Why Lockheed Martin's Earnings Miss Could Be a Blessing in Disguise

Lockheed’s earnings miss sent the stock to fresh lows, but with guidance intact and the stock deeply oversold, the setup is starting to look attractive.

3 ETFs to Play the Enterprise Software Slump

3 ETFs to Play the Enterprise Software Slump

Enterprise software providers have reached a major hurdle with AI, but this could mean a buy opportunity for investors willing to take on risk.

CPI Card Group’s Quiet Cash Machine Faces a Digital Reality Check

CPI Card Group’s Quiet Cash Machine Faces a Digital Reality Check

CPI Card Group stock shows strong cash flow and revenue growth, but acquisition costs, tariffs, and digital payment trends raise long-term questions.

2 ETFs to Play Both Sides of the Iran War Ceasefire

2 ETFs to Play Both Sides of the Iran War Ceasefire

ETFs focused on oil and air travel are two potential plays for different outcomes of the war between the United States and Iran.

Qualcomm’s 50% Surge: Bubble Territory or Breakout Moment?

Qualcomm’s 50% Surge: Bubble Territory or Breakout Moment?

Qualcomm looks technically stretched, but with a new growth story taking shape, this rally should still have room to run.

Get all your
news in one place.

100's of premium titles.
One news app.

Powering Up: UGI Banks $685M in Strategic Turnaround

UGI Corporation is divesting non-core assets to strengthen its balance sheet and sharpen its focus on its primary natural gas and propane distribution.

3 Emerging Markets ETFs to Maximize Exposure to High-Potential Countries

ETFs focused on emerging markets can give concentrated exposure to fast-growing markets at a time when the U.S. economy's growth prospects may falter.

Roblox Stock Slides to New Low as Safety Changes Weigh on Outlook

Roblox shares fall to a new low after lowering guidance tied to safety changes. Softer user trends and margin pressure are weighing on sentiment.

2 Stocks to Watch as the Quantum Space Gets More Crowded

A new product from Cisco and the anticipated IPO of Honeywell's Quantinuum are two of the latest factors complicating the landscape for existing quantum firms.

Get all your
news in one place.

100's of premium titles.
One news app.

Trump’s Rescheduling of Marijuana Is a Spark for Top Marijuana ETFs

Trump’s move to reschedule marijuana has sparked a cannabis stock rally. Despite past losses, ETFs like MJ and MSOS offer a speculative buy-low opportunity.

Q1 2026 Telecom Wars: Analyst Eye 30% Gains in T-Mobile Post-Earnings

Telecom giants reported solid results in Q1 2026. Analysts are particularly bullish on T-Mobile going forward, projecting over 30% upside.

Wall Street Loves TJX, But Is the Stock Still a Good Deal for Investors?

TJX stock has surged on consistent earnings beats and strong demand, but with growth expected to moderate, investors are weighing how much upside remains.

The AI Supercycle's Most Undervalued Manufacturer

Sanmina Corporation's strategic pivot into AI data center hardware manufacturing is driving triple-digit revenue growth and signaling a major valuation reset.

The Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It Launches

Dylan Jovine of Behind the Markets identifies five chip stocks set to benefit from the SpaceX IPO and the agentic AI wave driving it.

Visa Soars Post-Earnings; Outlook Positive Despite AI Risks

Visa's latest earnings were a big win for shares. Despite macro and AI fears, Visa powered ahead, posting its highest growth since 2022.

The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat

Big Pharma stalwarts AbbVie, AstraZeneca, and GSK beat Q1 revenue expectations, raising guidance and offering a potential tailwind for the flailing medical sector.

1 … 62 63 64 65

People

196,935 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Intel Corporation

International Monetary Fund

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Emerging Markets

Places

387,230 stories

The United States

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play